Specific niche view of the structured sector hierarchy. Useful for precedent work where broader sector slices include too much noise.
| Target | Buyer / Investor | Sector | Geo | Transaction size | EV / EBITDA |
|---|---|---|---|---|---|
| Becton Dickinson’s Biosciences & Diagnostics Unit | Waters | Bio Diagnostics & Testing | $15,000M | 16× – 21× | |
| Thermo Fisher Scientific microbiology business | Astorg | Bio Diagnostics & Testing | $1,075M | 7× – 9× | |
| International Analytical Services S.A.C. (INASSA) | Pacific Control | Bio Diagnostics & Testing | $14.3M – $19.3M | 6× – 8× | |
| Colibri Scientific Limited | Biofortuna Limited | Bio Diagnostics & Testing | $9.0M – $12.2M | 6× – 8× | |
| InformedDNA Genetic Testing Utilization Management business unit | Zyter | Bio Diagnostics & Testing | $33.0M – $44.6M | 7× – 10× | |
| Thermo Fisher Scientific global microbiology business | Astorg Partners | Bio Diagnostics & Testing | $1,075M | 7× – 9× | |
| Abscint SA | Curium | Bio Diagnostics & Testing | $22.1M – $29.9M | n/m | |
| Microbiology business from Thermo Fisher Scientific | Astorg | Bio Diagnostics & Testing | $1,352M – $1,829M | 11× – 15× | |
| Personalis, Inc. | Tempus AI, Inc. | Bio Diagnostics & Testing | $1,500M | n/m | |
| Personalis | Tempus AI, Inc. | Bio Diagnostics & Testing | $1,500M | 186.6× |
Bins are observed deal frequencies across disclosed transactions. Use as a directional reference, not a target valuation.
Use the directory on the recent deals hub to switch between countries, sectors and sub-sectors. A free account unlocks the structured filters that go beyond the public view.